PD24-03 EFFICACY AND SAFETY OF AFALAZA IN MEN WITH SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA AT RISK OF PROGRESSION: A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED CLINICAL TRIAL | Zendy

AI Assistant Blog Pricing

PD24-03 EFFICACY AND SAFETY OF AFALAZA IN MEN WITH SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA AT RISK OF PROGRESSION: A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED CLINICAL TRIAL

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.